Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.20p
   
  • Change Today:
      0.32p
  • 52 Week High: 5.34
  • 52 Week Low: 1.60
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 2,394,182
  • Market Cap: £33.33m
  • Beta: 0.02

Latest ShareCast News

Shield Therapeutics inks exclusive licence agreement in Japan

By Iain Gilbert

Date: Tuesday 22 Apr 2025

(Sharecast News) - Pharmacitucal firm Shield Therapeutics said on Tuesday that it had inked an exclusive licence agreement for its ACCRUFeR iron deficiency asset in Japan with VITAL-NET.

Shield Therapeutics appoints Anders Lundstrom as permanent CEO

By Josh White

Date: Monday 27 Jan 2025

(Sharecast News) - Shield Therapeutics announced the appointment of Anders Lundstrom as its permanent chief executive officer on Monday, effective 1 February.

Shield Therapeutics secures $10m investment, announces RetailBook offer

By Josh White

Date: Friday 06 Dec 2024

(Sharecast News) - Shield Therapeutics announced on Friday that it has secured a $10m investment from its largest shareholder, AOP Health International Management, through a subscription of 256.4 million new shares at 3p per share.

Shield Therapeutics reports strong quarter for A... 29-Oct-2024 ShareCast
Shield Therapeutics announces promising paediatr... 25-Sep-2024 ShareCast
Shield Therapeutics iron deficiency treatment ap... 27-Aug-2024 ShareCast
Shield Therapeutics net sales grow in Q2, CEO st... 24-Jul-2024 ShareCast
Shield Therapeutics reports strong US progress 07-Dec-2023 ShareCast
Shield's Canadian partner files new drug submiss... 21-Mar-2022 ShareCast
Shield Therapeutics revenue falls in line with e... 17-Feb-2022 ShareCast
Shield Therapeutics enters Accrufer licensing de... 05-Jan-2022 ShareCast
Shield shares surge on expansion of US coverage ... 16-Dec-2021 ShareCast
Shield Therapeutics appoints chief medical officer 27-Sep-2021 ShareCast
Shield Therapeutics swings to losses in first half 17-Aug-2021 ShareCast
Shield Therapeutics inks exclusive licence for '... 12-Aug-2021 ShareCast
Shield Therapeutics appoints industry veteran Gr... 28-May-2021 ShareCast
Shield taps Hans-Peter Rudolf as its new finance... 22-Mar-2021 ShareCast
Shield's Feraccru gets registration in Australia 09-Mar-2021 ShareCast
Shield Therapeutics FY trading in line with mark... 15-Jan-2021 ShareCast
Shield shares rise as Teva withdraws patent oppo... 19-Oct-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 3.20p
Change Today 0.32p
% Change 11.11 %
52 Week High 5.34
52 Week Low 1.60
Volume 2,394,182
Shares Issued 1,041.69m
Market Cap £33.33m
Beta 0.02

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.21% below the market average11.21% below the market average11.21% below the market average11.21% below the market average11.21% below the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Price Trend
40.34% above the market average40.34% above the market average40.34% above the market average40.34% above the market average40.34% above the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Income Not Available
Growth
63.02% above the market average63.02% above the market average63.02% above the market average63.02% above the market average63.02% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
16:40 5,000 @ 3.20p
16:40 5,000 @ 3.20p
16:24 44,817 @ 3.40p
16:12 29,446 @ 3.40p
16:01 2,000 @ 3.20p

STX Key Personnel

CEO Anders Lundstrom

Top of Page